Suzan Gharib
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suzan Gharib has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Faten Harb
Department of Allied Medical Professions, Associated Nursing Program, Technical College Middle East University Amman Jordan
2 shared publications - Mohammed Dibas
Department of Medicine, Faculty of Medicine and Health Sciences An‐Najah National University Nablus Palestine
2 shared publications - Omar Alqaisi
Nursing Department Al‐Zaytoonah University Amman Jordan
2 shared publications - Patricia Tai
Department of Oncology University of Saskatchewan Saskatoon Saskatchewan Canada
2 shared publications - Safia Darwish
Nursing Department Al‐Zaytoonah University Amman Jordan
1 shared publication
Latest Publications
- Open Access
- 12 September 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (9) , e72235
Mapping Multilevel Barriers and Facilitators to Inclusive Cancer Care for Sexual and Gender Minority Populations: A Scoping Review
Background: Cancer remains a leading cause of death worldwide, yet advances in prevention, screening, and treatment are not equitably shared. Lesbian, gay, bisexual, transgender, queer/questioning, intersex, asexual, and additional sexual and gender minority (LGBTQIA+) individuals face persistent disparities in cancer care across individual, interpersonal, and institutional levels. This scoping review aimed to improve cancer care for adult LGBTQIA+ patients by mapping and synthesizing evidence on multilevel barriers and facilitators to inclusive cancer care. Methods: A systematic search across PubMed, Scopus, ScienceDirect, and CINAHL was conducted for peer‐reviewed studies published between January 2015 and December 2025. Eligible studies examined cancer care accessibility, delivery, and patient experiences for LGBTQIA+ adults. Results: Twenty studies met the inclusion criteria. Findings revealed critical gaps in provider knowledge. Only 5% of healthcare professionals answered all LGBTQIA+ health questions correctly, 40% reported difficulty addressing sexual health, and 80% expressed interest in LGBTQIA+ training. Among LGBTQIA+ individuals, 65% were uncertain about cancer screening needs, and 76% had not received at least one human papilloma virus vaccine dose. Interpersonal barriers involved inadequate training, communication challenges, and implicit bias. Structural barriers included limited sexual orientation and gender identity fields in electronic records and registries, noninclusive environments, and weak institutional policies. Inclusive communication, routine sexual orientation and gender identity documentation, and visible signals of safety emerged as key facilitators. Conclusions: Inclusive cancer care for LGBTQIA+ adults requires coordinated interventions that address provider education, clinical communication, and system‐level structures simultaneously. Embedding mandatory LGBTQIA+ cultural‐competence training, integrating routine sexual orientation and gender identity collection into electronic health records, and creating visibly welcoming environments represent high‐priority, evidence‐informed strategies to reduce these disparities. Notably, expanding research that meaningfully includes the LGBTQIA+ population is critical toward more equitable cancer care.
- 12 September 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (9) , e72235
Open AccessMapping Multilevel Barriers and Facilitators to Inclusive Cancer Care for Sexual and Gender Minority Populations: A Scoping Review
Background: Cancer remains a leading cause of death worldwide, yet advances in prevention, screening, and treatment are not equitably shared. Lesbian, gay, bisexual, transgender, queer/questioning, intersex, asexual, and additional sexual and gender minority (LGBTQIA+) individuals face persistent disparities in cancer care across individual, interpersonal, and institutional levels. This scoping review aimed to improve cancer care for adult LGBTQIA+ patients by mapping and synthesizing evidence on multilevel barriers and facilitators to inclusive cancer care. Methods: A systematic search across PubMed, Scopus, ScienceDirect, and CINAHL was conducted for peer‐reviewed studies published between January 2015 and December 2025. Eligible studies examined cancer care accessibility, delivery, and patient experiences for LGBTQIA+ adults. Results: Twenty studies met the inclusion criteria. Findings revealed critical gaps in provider knowledge. Only 5% of healthcare professionals answered all LGBTQIA+ health questions correctly, 40% reported difficulty addressing sexual health, and 80% expressed interest in LGBTQIA+ training. Among LGBTQIA+ individuals, 65% were uncertain about cancer screening needs, and 76% had not received at least one human papilloma virus vaccine dose. Interpersonal barriers involved inadequate training, communication challenges, and implicit bias. Structural barriers included limited sexual orientation and gender identity fields in electronic records and registries, noninclusive environments, and weak institutional policies. Inclusive communication, routine sexual orientation and gender identity documentation, and visible signals of safety emerged as key facilitators. Conclusions: Inclusive cancer care for LGBTQIA+ adults requires coordinated interventions that address provider education, clinical communication, and system‐level structures simultaneously. Embedding mandatory LGBTQIA+ cultural‐competence training, integrating routine sexual orientation and gender identity collection into electronic health records, and creating visibly welcoming environments represent high‐priority, evidence‐informed strategies to reduce these disparities. Notably, expanding research that meaningfully includes the LGBTQIA+ population is critical toward more equitable cancer care.
- Open Access
- 20 May 2026
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (3) , e70241
Self‐Efficacy, Self‐Care, Glycaemic Control, and Quality of Life Among Adults With Type 2 Diabetes: A Scoping Review
Introduction: Type 2 diabetes mellitus (T2DM) is no longer just a metabolic diagnosis; it is a daily test of confidence, endurance and quality of life. Traditional measures such as haemoglobin A1c (HbA1c) provide only a partial picture, while patients' beliefs about their ability to manage diabetes may be equally crucial. This scoping review examines how self‐efficacy and self‐care behaviours intersect with glycaemic control and health‐related quality of life (HRQoL) in adults with T2DM across diverse health systems and cultures. Methods: Following the Arksey and O'Malley framework and PRISMA‐ScR guidelines, a systematic search was conducted across four databases covering January 2016 to March 2026. Studies were eligible if they included adults aged ≥ 18 years with confirmed T2DM and examined at least one of the following: diabetes self‐efficacy, self‐care behaviours, glycaemic control (HbA1c) or HRQoL. Thirteen studies encompassing 5784 adults with T2DM were included, spanning cross‐sectional, longitudinal, quasi‐experimental and randomised controlled trial designs across seven countries. Results: Diabetes management self‐efficacy consistently outperformed knowledge in predicting self‐care behaviours and HbA1c, with patients holding stronger efficacy beliefs demonstrating better metabolic control and higher HRQoL. Interventions grounded in social cognitive theory and empowerment approaches achieved clinically meaningful HbA1c reductions alongside improvements in self‐care and quality of life. Advanced modelling identified a psychological cascade whereby health literacy enhanced empowerment and self‐efficacy, which in turn drove self‐care and improved glycaemic and HRQoL outcomes. Cluster analyses further revealed distinct high‐risk subgroups, underscoring the need for stratified, individualised interventions. Conclusion: In T2DM, self‐efficacy consistently emerged as a central psychological factor associated with self‐care behaviour, glycaemic control and quality of life. The available evidence suggests that theoretically grounded, individually tailored interventions addressing psychological and behavioural determinants, including self‐efficacy, self‐care, empowerment and resilience, hold promise for improving diabetes outcomes. However, further longitudinal and experimental research is needed to confirm these relationships.
- 20 May 2026
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (3) , e70241
Open AccessSelf‐Efficacy, Self‐Care, Glycaemic Control, and Quality of Life Among Adults With Type 2 Diabetes: A Scoping Review
Introduction: Type 2 diabetes mellitus (T2DM) is no longer just a metabolic diagnosis; it is a daily test of confidence, endurance and quality of life. Traditional measures such as haemoglobin A1c (HbA1c) provide only a partial picture, while patients' beliefs about their ability to manage diabetes may be equally crucial. This scoping review examines how self‐efficacy and self‐care behaviours intersect with glycaemic control and health‐related quality of life (HRQoL) in adults with T2DM across diverse health systems and cultures. Methods: Following the Arksey and O'Malley framework and PRISMA‐ScR guidelines, a systematic search was conducted across four databases covering January 2016 to March 2026. Studies were eligible if they included adults aged ≥ 18 years with confirmed T2DM and examined at least one of the following: diabetes self‐efficacy, self‐care behaviours, glycaemic control (HbA1c) or HRQoL. Thirteen studies encompassing 5784 adults with T2DM were included, spanning cross‐sectional, longitudinal, quasi‐experimental and randomised controlled trial designs across seven countries. Results: Diabetes management self‐efficacy consistently outperformed knowledge in predicting self‐care behaviours and HbA1c, with patients holding stronger efficacy beliefs demonstrating better metabolic control and higher HRQoL. Interventions grounded in social cognitive theory and empowerment approaches achieved clinically meaningful HbA1c reductions alongside improvements in self‐care and quality of life. Advanced modelling identified a psychological cascade whereby health literacy enhanced empowerment and self‐efficacy, which in turn drove self‐care and improved glycaemic and HRQoL outcomes. Cluster analyses further revealed distinct high‐risk subgroups, underscoring the need for stratified, individualised interventions. Conclusion: In T2DM, self‐efficacy consistently emerged as a central psychological factor associated with self‐care behaviour, glycaemic control and quality of life. The available evidence suggests that theoretically grounded, individually tailored interventions addressing psychological and behavioural determinants, including self‐efficacy, self‐care, empowerment and resilience, hold promise for improving diabetes outcomes. However, further longitudinal and experimental research is needed to confirm these relationships.